A Long-term Extension Study of Ustekinumab in Pediatric Participants (NCT05092269)

🧪 Interventions in This Study

• Ustekinumab (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (48 Sites)

Showing the first 25 of 48 sites.

• Children's Center For Digestive Healthcare, Llc — Atlanta, Georgia
• Mount Sinai — New York, New York
• Levine Childrens at Atrium Health — Charlotte, North Carolina
• Pediatric Specialists Of Virginia — Fairfax, Virginia
• STAT Research S A — Buenos Aires,
• Hospital de Ninos de Cordoba — Córdoba,
• Centro de Investigaciones Medicas Tucuman — San Miguel de Tucumán,
• Huderf — Brussels,
• Cliniques Universitaires Saint Luc — Brussels,
• UZ Gent — Ghent,
• UZ Brussel — Jette,
• Uz Gasthuisberg — Leuven,
• Hôpital Necker — Paris,
• Universitaetsklinikum der RWTH Aachen — Aachen,
• Charite Universitatsmedizin Berlin Campus Virchow Klinikum — Berlin,
• Semmelweis Egyetem — Budapest,
• Debreceni Egyetem Klinikai Kozpont — Debrecen,
• Borsod Abauj Zemplen Varmegyei Kozponti Korhaz es Egyetemi Oktato Korhaz — Miskolc,
• Szabolcs Szatmar Bereg Varmegyei Oktatokorhaz — Nyíregyháza,
• Szegedi Tudomanyegyetem — Szeged,
• Yitzhak Shamir Medical Center — Beer Yaakov,
• Shaare Zedek Medical Center — Jerusalem,
• Sheba Medical Center — Ramat Gan,
• Fondazione IRCCS Ca Granda Ospedale Policlinico Di Milano — Milan,
• Juntendo University Hospital — Bunkyō City,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Crohn Disease

• Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease — Lutherville, Maryland
• Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial — New Haven, Connecticut
• A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease — Portland, Oregon
• Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) — Ottawa, Ontario
• Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease — Atlanta, Georgia

Explore by condition: All Crohn Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.